Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience
Current Issues in Molecular Biology · 06.04.2024 · 46 (4) · 3209-3217
DOI: 10.3390/cimb46040201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 06.04.2024. Verfasst von Katia Margiotti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fetal anomalies, characterized by structural or functional abnormalities occurring during intrauterine life, pose a significant medical challenge, with a notable prevalence, affecting approximately 2–3% of live births and 20% of spontaneous miscarriages. This study aims to identify the genetic cause of ultrasound anomalies through clinical exome sequencing (CES) analysis. The focus is on utilizing CES analysis in a trio setting, involving the fetuses and both parents. To achieve this objective, prenatal trio clinical exome sequencing was conducted in 51 fetuseses exhibiting ultrasound anomalies with previously negative results from chromosomal microarray (CMA) analysis. The study revealed pathogenic variants in 24% of the analyzed cases (12 out of 51). It is worth noting that the findings include de novo variants in 50% of cases and the transmission of causative variants from asymptomatic parents in 50% of cases. Trio clinical exome sequencing stands out as a crucial tool in advancing prenatal diagnostics, surpassing the effectiveness of relying solely on chromosomal microarray analysis. This underscores its potential to become a routine diagnostic standard in prenatal care, particularly for cases involving ultrasound anomalies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy.
- Fetal-Maternal Medical Centre, Altamedica Viale Liegi 45, 00198 Rome, Italy.
ORCID-Profile: Katia Margiotti, Marco Fabiani
Zitieren
APA
Margiotti, K., Fabiani, M., Cima, A., Libotte, F., Mesoraca, A., & Giorlandino, C. (2024). Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience. Current Issues in Molecular Biology, 46(4), 3209-3217. https://doi.org/10.3390/cimb46040201
Vancouver
Margiotti K, Fabiani M, Cima A, Libotte F, Mesoraca A, Giorlandino C. Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience. Current Issues in Molecular Biology. 2024;46(4):3209-3217. doi:10.3390/cimb46040201
BibTeX
@article{Margiotti2024,
author = {Margiotti, Katia and Fabiani, Marco and Cima, Antonella and Libotte, Francesco and Mesoraca, Alvaro and Giorlandino, Claudio},
title = {Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience},
journal = {Current Issues in Molecular Biology},
year = {2024},
volume = {46},
number = {4},
pages = {3209--3217},
doi = {10.3390/cimb46040201}
}
EUVIMED